Nancy
A
In a letter addressed to FDA Commissioner Robert Califf dated Thursday, a group of doctors and researchers called on the agency to revoke its approval, saying the test doesn’t predict opioid use disorder “any better than chance.”
08:42 AM - Apr 04, 2024
0
0
0

 

{{ notificationModalContent }} {{ promptModalMessage }}